Skip to main content Accessibility help
×
Home

Brief psychodynamic interpersonal psychotherapy for patients with multisomatoform disorder: randomised controlled trial

  • H. Sattel (a1), C. Lahmann (a2), H. Gündel (a3), E. Guthrie (a4), J. Kruse (a5), M. Noll-Hussong (a6), C. Ohmann (a7), J. Ronel (a1), M. Sack (a1), N. Sauer (a8), G. Schneider (a9) and P. Henningsen (a10)...

Abstract

Background

Multisomatoform disorder is characterised by severe and disabling bodily symptoms, and pain is one of the most common and impairing of these. Furthermore, these bodily symptoms cannot be explained by an underlying organic disorder. Patients with multisomatoform disorder are commonly found at all levels of healthcare and are typically difficult to treat for physicians as well as for mental health specialists.

Aims

To test whether brief psychodynamic interpersonal therapy (PIT) effectively improves the physical quality of life in patients who have had multisomatoform disorder for at least 2 years.

Method

We recruited 211 patients (from six German academic out-patient centres) who met the criteria for multisomatoform disorder for a randomised, controlled, 12-week, parallel-group trial from 1 July 2006 to 1 January 2009 (International Standard Randomised Controlled Trial Number ISRCTN23215121). We randomly assigned the patients to receive either 12 weekly sessions of PIT (n = 107) or three sessions of enhanced medical care (EMC, n = 104). The physical component summary of the Short Form Health Survey (SF-36) was the pre-specified primary outcome at a 9-month follow-up.

Results

Psychodynamic interpersonal therapy improved patients' physical quality of life at follow-up better than EMC (mean improvement in SF-36 score: PIT 5.3, EMC 2.2), with a small to medium between-group effect size (d = 0.42, 95% CI 0.15–0.69, P = 0.001). We also observed a significant improvement in somatisation but not in depression, health anxiety or healthcare utilisation.

Conclusions

This trial documents the long-term efficacy of brief PIT for improving the physical quality of life in patients with multiple, difficult-to-treat, medically unexplained symptoms.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Brief psychodynamic interpersonal psychotherapy for patients with multisomatoform disorder: randomised controlled trial
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Brief psychodynamic interpersonal psychotherapy for patients with multisomatoform disorder: randomised controlled trial
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Brief psychodynamic interpersonal psychotherapy for patients with multisomatoform disorder: randomised controlled trial
      Available formats
      ×

Copyright

Corresponding author

Prof. Dr med. Peter Henningsen, Department of Psychosomatic Medicine and Psychotherapy, Klinikum rechts der Isar, Technische Universität München, Langerstr. 3, D-81675 München, Germany. Email: p.henningsen@tum.de

Footnotes

Hide All

Declaration of interest

None.

Footnotes

References

Hide All
1 Barsky, AJ, Orav, EJ, Bates, DW. Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Arch Gen Psychiatry 2005; 62: 903–10.
2 Henningsen, P, Zipfel, S, Herzog, W. Management of functional somatic syndromes. Lancet 2007; 369: 946–55.
3 Kroenke, K, Sharpe, M, Sykes, R. Revising the classification of somatoform disorders: key questions and preliminary recommendations. Psychosomatics 2007; 48: 277–85.
4 Creed, F, Fink, P, Guthrie, E, Henningsen, P, Rief, W, Sharpe, M, et al. Is there a better term than ‘medically unexplained symptoms'? J Psychosom Res 2010; 68: 58.
5 American Psychiatric Association. Somatoform Disorders – American Psychiatric Association DSM-5 Development. APA, 2010 (http://www.dsm5.org/ProposedRevisions/Pages/SomatoformDisorders.aspx).
6 Fink, P, Schröder, A. One single diagnosis, bodily distress syndrome, succeeded to capture 10 diagnostic categories of functional somatic syndrome and somatoform disorders. J Psychosom Res 2010; 68: 415–25.
7 Kroenke, K. Patients presenting with somatic complaints: epidemiology, psychiatric comorbidity and management. Int J Methods Psychiatr Res 2003; 12: 3443.
8 Kroenke, K, Swindle, R. Cognitive–behavioral therapy for somatization and symptom syndromes: a critical review of controlled clinical trials. Psychother Psychosom 2000; 69: 205–15.
9 Abbass, A, Kisely, S, Kroenke, K. Short-term psychodynamic psychotherapy for somatic disorders: systematic review and meta-analysis of clinical trials. Psychother Psychosom 2009; 78: 265–74.
10 Kroenke, K. Efficacy of treatment for somatoform disorders: a review of randomized controlled trials. Psychosom Med 2007; 69: 881–8.
11 Hardy, G, Barkham, M, Shapiro, D, Guthrie, E, Margison, F (eds). Psychodynamic-Interpersonal Psychotherapy. Sage, 2011 (in press).
12 Kroenke, K, Spitzer, RL, deGruy, FV, Hahn, SR, Linzer, M, Williams, JB, et al. Multisomatoform disorder: an alternative to undifferentiated somatoform disorder for the somatizing patient in primary care. Arch Gen Psychiatry 1997; 54: 352–8.
13 Spitzer, RL, Kroenke, K, Williams, JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. JAMA 1999; 282: 1737–44.
14 Ware, JE, Sherbourne, CD. The MOS 36-item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Med Care 1992; 30: 473–83.
15 First, MB, Spitzer, RL, Gibbon, M, Williams, JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders. Biometrics Research, New York State Psychiatric Institute, 2002.
16 Folstein, MF, Folstein, SE, McHugh, PR. ‘Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189–98.
17 Seivewright, H, Green, J, Salkovskis, P, Barrett, B, Nur, U, Tyrer, P. Cognitive–behavioural therapy for health anxiety in a genitourinary medicine clinic: randomised controlled trial. Br J Psychiatry 2008; 193: 332–7.
18 Rudolf, G, Henningsen, P. Psychotherapeutic treatment of somatoform disorders [in German]. Z Psychosom Med Psychother 2003; 49: 319.
19 Guthrie, E. Adaptation of the psychodynamic-interpersonal model to work with medically unexplained symptoms. In Psychodynamic-Interpersonal Psychotherapy (eds Hardy, G, Barkham, M, Shapiro, D, Guthrie, E, Margison, F). Sage, 2011 (in press).
20 Henningsen, P, Working Group PISO. Psychodynamic-interpersonal therapy for somatoform disorders (PISO) – a manualized short-term psychotherapy [in German]. In Practice of Psychodynamic Psychotherapy [in German] (eds Beutel, M, Doering, S, Leichsenring, F, Reich, G). Hogrefe, 2011 (in press).
21 Rief, W, Henningsen, P. Somatoform disorders [in German]. In Practice of Psychotherapy [in German] (eds Senf, W, Broda, M). Thieme, 2005.
22 Shapiro, DA, Startup, M. Measuring therapist adherence in exploratory psychotherapy. Psychother Res 1992; 2: 193203.
23 Henningsen, P, Hartkamp, N, Loew, T, Sack, M, Scheidt, C, Rudolf, G. Somatoform Disorders. Guidelines and Source Book [in German]. Schattauer, 2002.
24 Riddle, DL, Lee, KT, Stratford, PW. Use of SF-36 and SF-12 health status measures: a quantitative comparison for groups versus individual patients. Med Care 2001; 39: 867–78.
25 Wiebe, S, Matijevic, S, Eliasziw, M, Derry, PA. Clinically important change in quality of life in epilepsy. J Neurol Neurosurg Psychiatry 2002; 73: 116–20.
26 Creed, F, Fernandes, L, Guthrie, E, Palmer, S, Ratcliffe, J, Read, N, et al. The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome. Gastroenterology 2003; 124: 303–17.
27 Kleinstaeuber, M, Witthoeft, M, Hiller, W. Efficacy of short-term psychotherapy for multiple medically unexplained physical symptoms: a meta-analysis. Clin Psychol Rev 2011; 31: 146–60.
28 Pilowsky, I. Dimensions of hypochondriasis. Br J Psychiatry 1967; 113: 8993.
29 Fink, P, Ewald, H, Jensen, J, S⊘rensen, L, Engberg, M, Holm, M, et al. Screening for somatization and hypochondriasis in primary care and neurological in-patients: a seven-item scale for hypochondriasis and somatization. J Psychosom Res 1999; 46: 261–73.
30 Altman, DG, Schulz, KF, Moher, D, Egger, M, Davidoff, F, Elbourne, D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001; 134: 663–94.
31 Cohen, J. Statistical Power Analysis for the Behavioral Sciences (2nd edn). Erlbaum, 1988.
32 Looper, KJ, Kirmayer, LJ. Behavioral medicine approaches to somatoform disorders. J Consult Clin Psychol 2002; 70: 810–27.
33 Fonagy, P. Psychotherapy research: do we know what works for whom? Br J Psychiatry 2010; 197: 83–5.
34 Roland, M, Torgerson, DJ. What are pragmatic trials? BMJ 1998; 316: 285.
35 Dickinson, WP, Dickinson, LM, deGruy, FV, Main, DS, Candib, LM, Rost, K. A randomized clinical trial of a care. recommendation letter intervention for somatization in primary care. Ann Fam Med 2003; 1: 228–35.
36 Sumathipala, A, Siribaddana, S, Abeysingha, MRN, De Silva, P, Dewey, M, Prince, M, et al. Cognitive–behavioural therapy v. structured care for medically unexplained symptoms: randomised controlled trial. Br J Psychiatry 2008; 193: 51–9.
37 Sattel, H, Kittner, A, Henningsen, P. A brief psychodynamic-interpersonal psychotherapy for patients with multisomatoform disorder (PISO) – one size fits all? Psychother Psych Med 2011; 61: 111.
38 Krause, MS, Lutz, W. What should be used for baselines against which to compare treatments’ effectiveness? Psychother Res 2009; 19: 358–67.
39 Morriss, R, Dowrick, C, Salmon, P, Peters, S, Dunn, G, Rogers, A, et al. Cluster randomised controlled trial of training practices in reattribution for medically unexplained symptoms. Br J Psychiatry 2007; 191: 536–42.
40 Guthrie, E, Moorey, J, Margison, F, Barker, H, Palmer, S, McGrath, G, et al. Cost-effectiveness of brief psychodynamic-interpersonal therapy in high utilizers of psychiatric services. Arch Gen Psychiatry 1999; 56: 519–26.

Brief psychodynamic interpersonal psychotherapy for patients with multisomatoform disorder: randomised controlled trial

  • H. Sattel (a1), C. Lahmann (a2), H. Gündel (a3), E. Guthrie (a4), J. Kruse (a5), M. Noll-Hussong (a6), C. Ohmann (a7), J. Ronel (a1), M. Sack (a1), N. Sauer (a8), G. Schneider (a9) and P. Henningsen (a10)...

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Brief psychodynamic interpersonal psychotherapy for patients with multisomatoform disorder: randomised controlled trial

  • H. Sattel (a1), C. Lahmann (a2), H. Gündel (a3), E. Guthrie (a4), J. Kruse (a5), M. Noll-Hussong (a6), C. Ohmann (a7), J. Ronel (a1), M. Sack (a1), N. Sauer (a8), G. Schneider (a9) and P. Henningsen (a10)...
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *